Blog
What is Translational Research in Oncology?
11/03/2022
Translational research takes scientific findings from more basic patient settings and translates these into insights that are used to develop treatment options. In essence, translational research establishes a bridge between basic research and clinical practice. Translational research has become increasingly popular in biomedical sciences over recent years, particularly in the field of oncology. This approach […]
Dose escalation clinical trials
10/03/2022
During phase 1 clinical trials, it is essential to establish safe and recommended dosages of the study drug or treatment. To determine this, dose escalation methods are used to examine the most tolerable dosage of the drug in patients early on in the trial. Read about the stages of clinical trials. The objective of dose […]
The Changing Landscape for Women in the Workplace
07/03/2022
On this International Women’s Day, we look at some of the ways in which the environment for women in the workplace has changed in the last five years. Firstly, there has been slow but positive progress in gender diversity in senior leadership roles over that time. In 2018, the proportion of senior roles held by […]
Rare Disease Day 2022: Urea Cycle Disorders
18/02/2022
Urea Cycle Disorders are a group of inherited diseases that causes a deficiency in one of the enzymes involved in the urea cycle. Each sub-type of the disorder group is named after the particular enzyme that is deficient. The urea cycle converts the nitrogen which is a waste product of protein metabolism into ammonia in […]
Rare Disease Day 2022: Idiopathic Pulmonary Fibrosis
18/02/2022
Idiopathic Pulmonary Fibrosis (IPF) has an estimated prevalence of 13 to 20 per 100,000 people worldwide* and is a condition that typically affects people between the age of 50 and 70. It is rarely seen in those under 50 years of age. Symptoms of the condition develop gradually and can include a persistent dry cough, […]
Rare Disease Day 2022: Cystic Fibrosis
18/02/2022
More than 70,000 children and adults are affected by Cystic Fibrosis (CF) worldwide.* Cystic Fibrosis is a progressive, inherited disease which causes the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein to become dysfunctional. This results in the protein being unable to move chloride to the cell surface with the consequence that the cell is then […]
How are new drugs developed and tested?
16/02/2022
Many thousands of new drugs are developed every year. Before these can be administered by doctors and hospitals, they must undergo a thorough development and testing process. Drug development (also known as pharmaceutical product development) is a lengthy process, involving several important steps to ensure the drug is effective, safe and beneficial. It takes several […]
